2017 In Review: FDA's Cosmetics Slowdown Could Bolster Case For Legislative Jumpstart
This article was originally published in The Rose Sheet
FDA's cosmetics activities fell off noticeably compared with 2016, and the change in the White House spurred the agency to begin looking for regulatory burdens to eliminate while shuffling priorities away from cosmetics to make do with proposed cuts in federal funding. In this climate, robust cosmetics oversight may depend on a legislative update, with multiple draft bills on the table.
You may also be interested in...
New accounts are up 156% from 2014 in FDA’s Voluntary Cosmetic Registration Program, according to FDA, which has made improvements to streamline the submission process for participants and lighten the load on agency staffers. Further changes recommended by industry are currently under consideration.
Another retailer of cosmetics aimed at girls, Claire's, faces allegations of asbestos-contaminated makeup products, less than six months after tweens-focused Justice came under similar fire. Both retailers say their own independent testing showed products in question to be asbestos-free, but the PR damage may be done.
Rose Sheet's coverage of consumer litigation targeting personal-care companies for deceptive claims, among other alleged violations, yielded some of its most-read stories in 2017, based on online analytics. Trends are likely to carry over and, in some cases, pick up steam in 2018.